Auris in The Wall Street Journal

Apr 12 2018

WSJ Pro


Auris Health is featured for its innovative technology and its co-founder, Dr. Fred Moll, who helped pioneer Auris’s beginnings. Dr. Moll, a serial entrepreneur and surgical robotics visionary, references in the article the growing need for more precise, capable hands in minimally invasive surgeries.

According to the article, Auris’s Monarch Platform combines advancements in robotics, software and other fields. The system was cleared by the FDA in late March for diagnostic and therapeutic use in the airways. While lung cancer is the company’s first target, Auris envisions additional uses for the technology across future endoscopic clinical indications.

View the Full Article on Auris



Back to all News